NCT01449565View on ClinicalTrials.gov

Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM)

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

March 31, 2016

Conditions
Amphetamine-Related Disorders
Interventions
DRUG

Naltrexone

3 monthly intramuscular injections of naltrexone 380 mg (extended release)

DRUG

Placebo

3 monthly intramuscular injections of placebo, matched to naltrexone 380 mg (extended release)

Trial Locations (1)

94102

Substance Use Research Unit, San Francisco

Sponsors

Collaborators (1)

Alkermes, Inc.
All Listed Sponsors
collaborator

Alkermes, Inc.

INDUSTRY

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

San Francisco Department of Public Health

OTHER_GOV